Ignite Creation Date:
2024-05-05 @ 6:41 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00524667
Status:
TERMINATED
Last Update Posted:
2011-07-20
First Post:
2007-08-31
Brief Title:
HDAC Inhibitor Valproic Acid as an Effective Therapy for Chronic Lymphocytic Leukemia
Sponsor:
CancerCare Manitoba
Organization:
CancerCare Manitoba
Organization Data
Organization:
CancerCare Manitoba
Class:
OTHER
Study ID:
CCM-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
CancerCare Manitoba
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Dr David Szwajcer Principal Investigator
Old Organization:
CancerCare Manitoba
Collaborators
| Name | Class |
|---|---|
| The Leukemia and Lymphoma Society | OTHER |